New EU Scrutiny Procedure Less Widely Applicable And Less Complex Than Expected
This article was originally published in Clinica
Executive Summary
One of the greatest hurdles in the future medtech Regulations – the highly demanding scrutiny procedures for high-risk devices and IVDs – now looks less widely applicable than industry had expected. Amanda Maxwell spoke with MedTech Europe’s John Brennan and Jesus Rueda to find out more